Nipent

Active Ingredient(s): Pentostatin
FDA Approved: * October 11, 1991
Pharm Company: * SUPERGEN
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Nipent Overview

Pentostatin (or deoxycoformycin, trade name Nipent, manufactured by SuperGen) is an anticancer chemotherapeutic drug.[1] Mechanism It is classified as a purine analog, which is a type of antimetabolite. It mimics the nucleoside adenosine and thus inhibits the enzyme adenosine deaminase, interfering with the cell's ability to process DNA.[2] Cancer cells generally divide more often than healthy cells; DNA is highly involved in cell division (mitosis) and drug...

Read more Nipent Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pentostatin

Recent Nipent Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Nipent: (1 result)

Sorted by National Drug Code

• 0409-0801 Nipent 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.

Other drugs which contain Pentostatin or a similar ingredient: (1 result)

• PENTOSTATIN 1 discussion